Andy obtained his B.Sc. in Chemistry from the University of Bristol and his D.Phil in Biological Chemistry from the University of Oxford. He then moved to Cambridge University as the Schering Fellow of Bioorganic Chemistry, followed by a Research Fellowship at St Catherine’s College; this was where his interest in biological mass spectrometry was kindled on one of the first commercial electrospray instruments, as well developing an multidisciplinary approach to research combining chemistry, biology and technology to study Vitamin B12 biosynthesis. He left Cambridge to take up a lectureship in Chemistry at the University of Strathclyde, before moving to the University of Glasgow in 2005 to Head the Proteomics Facility in the Sir Henry Wellcome Functional Genomics Facility (SHWFGF). He then became Director of the SHWFGF, set up the Scottish Metabolomics and Biomarker Discovery Facilities, and lead the Doctoral Training Centre in Cell and Proteomic Technologies. In 2011 he moved to Aston University where he holds the Chair of Pharmaceutical Chemistry and Chemical biology in the School of Pharmacy, and is also currently Associate Dean for Research for Life and Health Sciences. His research is multridisciplinary, spanning chemistry to the clinical sciences. He has a particular interest in the application of chemical methods, engineering and mathematical modelling for the development of new technologies and methodologies to study some of biology’s more challenging problems, such as the role of protein interactions in the exquisite control of cellular signalling, and the effect of protein modifications on these. Andy is currently President of the British Society for Proteome Research and a member of the Executive Council of EuPA, where he convenes the Journals Committee.
Associate Dean of Research, Life and Health Sciences
Professor of Pharmaceutical Chemisty and Chemical Biology